Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica

J Rheumatol. 2010 May;37(5):1075-6. doi: 10.3899/jrheum.091185.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use
  • Female
  • Humans
  • Polymyalgia Rheumatica / therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab